GLWLF
Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products in North America. The company engages in the commercialization of two technologies, such as MyCell Enhanced technology, a nutraceutical and cannabis nutrient delivery technology; and a cannabis Smart Consumption System to assist users and patients to store, journal, control, consume, and manage cannabis related products. The company has the exclusive North American rights for the production, sale, and distribution rights for the certain micellization technology for cannabis and hemp derived ingredients, curcumin, vitamin K, and iron. It also engages in the business of secondary processing of ingredients to produce micellized materials from certain vitamins, nutraceuticals, and cannabis extracts that makes fat-soluble substances available for immediate absorption into the body reach near 100% bioavailability and water compatibility. The company was incorporated in 2018 and is based in Toronto, Canada.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | 0.00 | $645,181 | -$324,665 |
| 2025 Q4 | 0.00 | $507,810 | $54,734 |
| 2025 Q3 | -0.00 | $630,791 | $100,594 |
| 2025 Q2 | -0.00 | $436,325 | -$55,707 |
| 2025 Q1 | -0.00 | $478,327 | -$217,873 |
| 2024 Q4 | -0.02 | $307,238 | -$249,970 |
| 2024 Q3 | -0.01 | $227,052 | -$571,648 |
| 2024 Q2 | -0.00 | $147,205 | -$167,147 |